EVAg

Infectious supernatant of Lassa virus. The virus has 98% sequence similarity to LASV strain LiB07-444 (GenBank accession no. GU830834) based on sequencing of PCR amplicon of partial glycoprotein precursor.

Infectious cell culture supernatant containing Zaire ebolavirus. The virus is preserved in Viral Storage Medium at -150°C. Tests for the presence of mycoplasmae were negative.

Infectious cell culture supernatant of Crimean-Congo hemorrhagic fever virus [Iran]. The virus is fully sequenced and it is preserved in Viral Storage Medium at -150°C. Tests for the presence of mycoplasmae was positive.

Infectious culture supernatant of SARS-CoV-2, hCoV-19/Sweden/21-51217/2021 (lineage B. 1. 351, ex South African variant); sequenced

Culture supernatant of SARS-CoV-2, hCoV-19/Sweden/20-53840/2020 (lineage B 1. 1 .7, ex UK); sequenced

Culture supernatant of SARS-CoV-2, hCoV-19/Sweden/20-53787/2020 (lineage B 1. 1 .7, ex UK); NGS

Culture supernatant of SARS-CoV-2, hCoV-19/Sweden/20-53846/2020 (lineage B 1. 1 .7, ex UK); complete genome sequence

IF-slides to detect anti-nCoV antibodies by Immunofluorescence assay. The slides were prepared by infecting Vero cells with the first Swedish SARS-CoV-2 isolate (SARS-CoV-2/01/human/2020/SWE). The virus is fully sequenced (Genebank accession: MT093571). The slides are fixated in acetone, air-dried and preserved at -80°C. IF-analysis tested positive with SARS-CoV-2 infected human sera.

In-house IF-slides to detect anti-CCHFV antibodies by Immunofluorecence assay. The slides were prepared by infecting Vero cells with the CCHFV strain, Nigerian IbAr10200. The slides are fixated in acetone, air-dried and preserved at -80°C. The slide has been tested positive with mouse monoclonal anti-CCHFV antibodies against N, Gc and Gn.

In-house slides to detect anti-EBOV antibodies by Immunofluorecence assay. The slides are fixated and preserved at -80°C. The slide has been tested positive with three different anti-EBOV antibodies; anti-Gp, anti-VP40, and anti-NP antibodies.